| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―23 |
Efficacy of intravenous immunoglobulin therapy in hospitalised patients with COVID-19: A randomized controlled trial |
Behrooz Ghezelbash, Alireza Mafi, Mehdi Rostami, Negah Tavakol, Raziyeh Salami, Yasaman Gholinezhad, et al. (+3) Mohammadreza Kasravi, Alireza Rajbzadeh, Nahid Eskandari |
| 2 |
[GO] |
2025―Feb―23 |
Alpha 1-antitrypsin as a potent biomarker for monitoring of disease severity in patients with Covid-19 and its correlation with Liver Enzymes and Lactate Dehydrogenase |
Mohammad Salehi, Abbas Sahebghadam Lotfi |
| 3 |
[GO] |
2024―Aug―18 |
MicroRNA-296-5p Expression in COVID-19 Patients and its Relationship with Inflammatory Cytokines |
Sepideh Barzin Tond, Sahar Yarahmadi, Reza Fadaei, Navid Farahmandian, Mohammadjavad Sotoudeheian, Rahim Rostami, et al. (+6) Nasim Khajavirad, Abbas Tafakhori, Minoosh Shabani, Ali Riazi, So�h Fallah, Saeed Karima |
| 4 |
[GO] |
2024―Aug―11 |
Effects of Plasma Therapy on Laboratory Factors and Clinical Improvement of COVID-19 Patients |
Behrooz Ghezelbash, Marjan Golabi, Negah Tavakol, Azam Mesgari, Reihaneh Shamsfar, Ramin Sami, Nahid Eskandari |
| 5 |
[GO] |
2023―Dec―30 |
Assessment of Leukocyte Subtypes to High-Density Lipoprotein-Cholesterol (HDL-C) Ratios as predictors of Severity and Mortality in COVID-19 Patients |
Hossein Hosseini, Marzieh Rohani-Rasaf, Akram Vatannejad, Asma Kheirollahi, Maryam Shabani, Maryam Teimouri |
|
